A study recently published by the specialized journal Nature revealed a side effect of anti-covid vaccines, namely, related to the eyes. They more than double the risk of incurable retinal vessel blockages, the publication writes.

Ophthalmological examinationPhoto: Dr P. Marazzi / Sciencephoto / Profimedia Images

The study is entitled “Evaluation of the risk of retinal vessel occlusion after vaccination against COVID-19” and was published on May 3 in the journal “Nature”.

The problem of eye damage is discussed, which, at least at the current level of medical development, is practically irreparable.

“As time goes on, the scale of the impact of experimental vaccines on human health is becoming more and more clear. And these are also negative. “But instead of stricter regulation, the European Union is now taking a step forward when it comes to mRNA substances,” commented the Frankfurter Allgemeine Zeitung in its online edition.

Double risk of retinal vessel occlusion

A total of seven million people were selected for this study. However, just under 750,000 vaccinated and about 3.8 million unvaccinated remained in the study after subjects were controlled for potentially confounding variables such as certain diseases, medications, and contraceptives. This choice was intended to prevent bias in the results.

“We were able to demonstrate a higher risk and incidence rate of retinal vessel occlusion after vaccination against Covid-19 after excluding possible confounding,” the researchers wrote. “The risk of retinal vessel occlusion, in addition to CRAO, was immediately observed in people vaccinated against SARS-CoV-2. Risk factors for retinal vascular occlusion include diabetes, hypertension, obesity, coronary heart disease, and stroke.”

Taken together, the results showed that “two years after vaccination, the probability of all subtypes (BRAO, BRVO, CRAO, and BRVO) of retinal vessel occlusion was significantly increased in the vaccinated segment.”

The study concluded: “The overall risk of retinal vessel occlusion at two years was 2.19 times higher in the vaccinated segment than in the unvaccinated segment.” In addition, “no differences were found between vaccine brands and dosage.”